Skip to main content
Figure 3 | Molecular Cancer

Figure 3

From: A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

Figure 3

Kaplan-Meier and log-rank analysis for 88 neuroblastoma patients. OS (A) and EFS (B) of patients classified according to the NB-hypo. OS (C) of patients classified according to 4 VEGF probesets. OS (D) of patients classified according to dendritic cells hypoxia signature. Solid and dashed curves represent good and poor prognosis patients, respectively. The p-value of the log-rank test is shown.

Back to article page

Molecular Cancer

ISSN: 1476-4598